Table 3.
Interrupted time series regression analysis for the number of users who received care by SIS, EPS, and FISSAL by type of Charlson’s disease.
| Coefficient | p | 95% CI | |||
|---|---|---|---|---|---|
| Cancer | Change in the number of users | − 21,249 | 0.000 | − 29,070 | − 13,428 |
| Change in trend | 1175 | 0.000 | 703 | 1647 | |
| Solid metastatic tumor | Change in the number of users | − 716 | 0.000 | − 977 | − 455 |
| Change in trend | 67 | 0.000 | 44 | 89 | |
| Dementia | Change in the number of users | − 1067 | 0.000 | − 1255 | − 879 |
| Change in trend | 22 | 0.002 | 8 | 35 | |
| Diabetes with complications | Change in the number of users | − 6204 | 0.000 | − 7336 | − 5073 |
| Change in trend | 35 | 0.347 | − 39 | 109 | |
| Diabetes without complications | Change in the number of users | − 33,447 | 0.000 | − 43,781 | − 23,114 |
| Change in trend | 1153 | 0.003 | 412 | 1895 | |
| Cerebrovascular disease | Change in the number of users | − 3950 | 0.000 | − 4719 | − 3182 |
| Change in trend | 77 | 0.004 | 25 | 130 | |
| Mild liver disease | Change in the number of users | − 7347 | 0.000 | − 8551 | − 6143 |
| Change in trend | 141 | 0.000 | 65 | 218 | |
| Moderate liver disease | Change in the number of users | − 649 | 0.000 | − 754 | − 544 |
| Change in trend | 12 | 0.000 | 6 | 19 | |
| Chronic pulmonary disease | Change in the number of users | − 31,365 | 0.000 | − 38,386 | − 24,344 |
| Change in trend | 695 | 0.000 | 357 | 1033 | |
| Kidney disease | Change in the number of users | − 8741 | 0.000 | − 10,545 | − 6937 |
| Change in trend | 124 | 0.018 | 22 | 227 | |
| Rheumatic disease | Change in the number of users | − 7518 | 0.000 | − 9005 | − 6030 |
| Change in trend | 185 | 0.000 | 87 | 283 | |
| Peptic ulcer | Change in the number of users | − 1206 | 0.000 | − 1453 | − 960 |
| Change in trend | 41 | 0.000 | 26 | 57 | |
| Peripheral vascular disease | Change in the number of users | − 512 | 0.000 | − 597 | − 426 |
| Change in trend | 11 | 0.000 | 5 | 17 | |
| Myocardial infarction | Change in the number of users | − 364 | 0.000 | − 462 | − 267 |
| Change in trend | 8 | 0.019 | 1 | 14 | |
| Congestive heart failure | Change in the number of users | − 3734 | 0.000 | − 4340 | − 3129 |
| Change in trend | 46 | 0.025 | 6 | 86 | |
| Paraplegia and hemiplegia | Change in the number of users | − 1248 | 0.000 | − 1465 | − 1032 |
| Change in trend | 34 | 0.000 | 20 | 49 | |
| AIDS/HIV | Change in the number of users | − 5363 | 0.000 | − 6581 | − 4144 |
| Change in trend | 101 | 0.016 | 19 | 182 | |
Change in the number of users at the beginning of the COVID-19 pandemic (change in the intercept). Change in the monthly trend regarding the number of users who received care during the pandemic (change in the slope [interaction]). SIS comprehensive health insurance (in Spanish). EPS private healthcare entities (in Spanish). FISSAL intangible solidarity health fund (in Spanish).